Litigation Resolved With $775M Settlement for Patients Prescribed Blood Thinner

18:10 EDT 25 Mar 2019 | Pharmacy Times

Bayer Healthcare and Janssen Pharmaceuticals Inc., the makers of the Xarelto® (rivaroxaban), agreed to resolve approximately 25,000 state and federal claims about the drug with payment.

More From BioPortfolio on "Litigation Resolved With $775M Settlement for Patients Prescribed Blood Thinner"